Quantification of Crystallinity in Substantially Amorphous Materials by Synchrotron X-ray Powder Diffractometry
- 715 Downloads
The aim of this study was to develop a highly sensitive powder X-ray diffraction (XRD) technique for quantification of crystallinity in substantially amorphous pharmaceuticals, utilizing synchrotron radiation and a 2-D area detector.
Diffraction data were acquired at the European Synchrotron Radiation Facility (France) using a 2-D charge-coupled device detector. The crystallization of amorphous sucrose was monitored in situ, isothermally at several temperatures in the range of 90 to 160°C. An algorithm was developed for separation of the crystalline and amorphous intensities from the total diffraction pattern.
The synchrotron XRD technique allowed powder diffraction patterns to be recorded with a time resolution of 40 ms. The gradual crystallization of sucrose is analogous to a series of physical mixtures with increasing content of the crystalline component. The in situ crystallization approach circumvented the problem of inhomogeneity in mixing—a potentially serious issue at extreme mixture compositions. The estimated limit of detection of crystalline sucrose in an amorphous matrix was 0.2% w/w, a considerable improvement over the reported value of ∼1% w/w with a conventional XRD.
High-intensity XRD can discern subtle changes in the lattice order of materials. The first evidence of crystallization can serve as an indicator of the potential physical instability of the product.
Key Wordsamorphous crystallinity pharmaceuticals synchrotron X-ray diffraction
- 3.Mullins, J. D., Macek, T. J. 1960Some pharmaceutical properties of novobiocinJ. Am. Pharm. Assoc.49245248Google Scholar
- 4.Tanaka, K., Takeda, T., Miyajima, K. 1991Cryoprotective effect of saccharides on denaturation of catalase by freeze-dryingChem. Pharm. Bull.3910911094Google Scholar
- 8.International Conference on Harmonisation (ICH)2000Draft guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substancesFed. Regist.658304183063Google Scholar
- 9.U.S. Department of Health and Human Services, Food and Drug Administration2003Process analytical technology—a framework for innovative pharmaceutical manufacturing and quality assurance. Draft guidanceFed. Regist.685278152782Google Scholar
- 15.Suryanarayanan, R. 1995
X-ray powder diffractometryBrittain, H. G. eds. Physical Characterization of Pharmaceutical SciencesMarcel DekkerNew York187221Google Scholar
- 18.Surana, R., Suryanarayanan, R. 2000Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X-ray powder diffractometryPowder Diffr.1526Google Scholar
- 23.Mahendrasingam, A., Fuller, W., Forsyth, V. T., Oldman, R. J., MacKerron, D., Blundell, D. J. 1992X-ray camera for high- and small-angle X-ray diffraction studies of the drawing and annealing of polymers at Daresbury Synchrotron Radiation SourceRev. Sci. Instrum.6310871090Google Scholar
- 24.C. Nunes. Use of High-Intensity X-Radiation in Solid-State Characterization of Pharmaceuticals, Ph.D. Dissertation, Department of Pharmaceutics, University of Minnesota, 2005.Google Scholar
- 25.Mahendrasingam, A., Martin, C., Bingham, S., Fuller, W., Blundell, D. J. 2000Synchrotron studies of polymers at high spatial and temporal resolutionAdv. X-ray Anal.43356365Google Scholar
- 27.Hughes, D. J., Mahendrasingam, A., Martin, C., Oatway, W. B., Heeley, E. L., Bingham, S. J., Fuller, W. 1999An instrument for the collection of simultaneous small and wide angle X-ray scattering and stress–strain data during deformation of polymers at high strain rates using synchrotron radiation sourcesRev. Sci. Instrum.7040514054CrossRefGoogle Scholar
- 28.Powder Diffraction File (PDF-2), International Centre for Diffraction Data, Newtown Square, PA, 1998.Google Scholar
- 29.Zografi, G. 1988States of water associated with solidsDrug Dev. Ind. Pharm.1419051926Google Scholar
- 30.Kontny, M. J., Zografi, G. 1995
Sorption of water by solidsBrittain, H. G. eds. Physical Characterization of Pharmaceutical SolidsMarcel DekkerNew York387418Google Scholar
- 36.Skoog, D. A., Leary, J. J. 1992Principles of Instrumental AnalysisHarcourt Brace CollegeForth Worth, TXGoogle Scholar
- 37.Thomsen, V., Schatzlein, D., Mercuro, D. 2003Limits of detection in spectroscopySpectroscopy18112114Google Scholar